Airway	B:C0458827
inflammation	O
phenotype	O
prediction	O
in	O
asthma	O
patients	O
using	O
lung	O
sound	O
analysis	I:C0022885
with	O
fractional	O
exhaled	O
nitric	O
oxide	O

Airway	O
inflammation	B:C0021368
phenotype	O
prediction	O
in	O
asthma	O
patients	O
using	O
lung	O
sound	O
analysis	I:C0022885
with	O
fractional	O
exhaled	O
nitric	O
oxide	O

Airway	O
inflammation	O
phenotype	O
prediction	O
in	O
asthma	B:C0004096
patients	O
using	O
lung	O
sound	O
analysis	I:C0022885
with	O
fractional	O
exhaled	O
nitric	O
oxide	O

Airway	O
inflammation	O
phenotype	O
prediction	O
in	O
asthma	O
patients	O
using	O
lung	B:C0024109
sound	O
analysis	I:C0022885
with	O
fractional	O
exhaled	O
nitric	O
oxide	O

Airway	O
inflammation	O
phenotype	O
prediction	O
in	O
asthma	O
patients	O
using	O
lung	O
sound	B:C0022885
analysis	I:C0022885
with	O
fractional	O
exhaled	O
nitric	O
oxide	O

We	O
previously	O
reported	O
the	O
results	O
of	O
lung	B:C0024109
sound	O
analysis	I:C0022885
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
and	O
demonstrated	O
that	O
the	O
exhalation	O
-	O
to	O
-	O
inhalation	O
sound	O
pressure	O
ratio	O
in	O
the	O
low	O
frequency	O
range	O
between	O
100	O
and	O
200	O
Hz	O
(	O
E	O
/	O
I	O
LF	O
)	O
was	O
correlated	O
with	O
the	O
presence	O
of	O
airway	O
inflammation	O
and	O
airway	O
obstruction	I:C0001883
.	O

We	O
previously	O
reported	O
the	O
results	O
of	O
lung	O
sound	B:C0022885
analysis	I:C0022885
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
and	O
demonstrated	O
that	O
the	O
exhalation	O
-	O
to	O
-	O
inhalation	O
sound	O
pressure	O
ratio	O
in	O
the	O
low	O
frequency	O
range	O
between	O
100	O
and	O
200	O
Hz	O
(	O
E	O
/	O
I	O
LF	O
)	O
was	O
correlated	O
with	O
the	O
presence	O
of	O
airway	O
inflammation	O
and	O
airway	O
obstruction	I:C0001883
.	O

We	O
previously	O
reported	O
the	O
results	O
of	O
lung	O
sound	O
analysis	I:C0022885
in	O
patients	O
with	O
bronchial	B:C0004096
asthma	I:C0004096
and	O
demonstrated	O
that	O
the	O
exhalation	O
-	O
to	O
-	O
inhalation	O
sound	O
pressure	O
ratio	O
in	O
the	O
low	O
frequency	O
range	O
between	O
100	O
and	O
200	O
Hz	O
(	O
E	O
/	O
I	O
LF	O
)	O
was	O
correlated	O
with	O
the	O
presence	O
of	O
airway	O
inflammation	O
and	O
airway	O
obstruction	I:C0001883
.	O

We	O
previously	O
reported	O
the	O
results	O
of	O
lung	O
sound	O
analysis	I:C0022885
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
and	O
demonstrated	O
that	O
the	O
exhalation	B:C0231800
-	O
to	O
-	O
inhalation	O
sound	O
pressure	O
ratio	O
in	O
the	O
low	O
frequency	O
range	O
between	O
100	O
and	O
200	O
Hz	O
(	O
E	O
/	O
I	O
LF	O
)	O
was	O
correlated	O
with	O
the	O
presence	O
of	O
airway	O
inflammation	O
and	O
airway	O
obstruction	I:C0001883
.	O

We	O
previously	O
reported	O
the	O
results	O
of	O
lung	O
sound	O
analysis	I:C0022885
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
and	O
demonstrated	O
that	O
the	O
exhalation	O
-	O
to	O
-	O
inhalation	B:C0004048
sound	O
pressure	O
ratio	O
in	O
the	O
low	O
frequency	O
range	O
between	O
100	O
and	O
200	O
Hz	O
(	O
E	O
/	O
I	O
LF	O
)	O
was	O
correlated	O
with	O
the	O
presence	O
of	O
airway	O
inflammation	O
and	O
airway	O
obstruction	I:C0001883
.	O

We	O
previously	O
reported	O
the	O
results	O
of	O
lung	O
sound	O
analysis	I:C0022885
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
and	O
demonstrated	O
that	O
the	O
exhalation	O
-	O
to	O
-	O
inhalation	O
sound	O
pressure	O
ratio	O
in	O
the	O
low	O
frequency	O
range	O
between	O
100	O
and	O
200	O
Hz	O
(	O
E	O
/	O
I	O
LF	O
)	O
was	O
correlated	O
with	O
the	O
presence	O
of	O
airway	B:C0458827
inflammation	O
and	O
airway	O
obstruction	I:C0001883
.	O

We	O
previously	O
reported	O
the	O
results	O
of	O
lung	O
sound	O
analysis	I:C0022885
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
and	O
demonstrated	O
that	O
the	O
exhalation	O
-	O
to	O
-	O
inhalation	O
sound	O
pressure	O
ratio	O
in	O
the	O
low	O
frequency	O
range	O
between	O
100	O
and	O
200	O
Hz	O
(	O
E	O
/	O
I	O
LF	O
)	O
was	O
correlated	O
with	O
the	O
presence	O
of	O
airway	O
inflammation	B:C0021368
and	O
airway	O
obstruction	I:C0001883
.	O

We	O
previously	O
reported	O
the	O
results	O
of	O
lung	O
sound	O
analysis	I:C0022885
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
and	O
demonstrated	O
that	O
the	O
exhalation	O
-	O
to	O
-	O
inhalation	O
sound	O
pressure	O
ratio	O
in	O
the	O
low	O
frequency	O
range	O
between	O
100	O
and	O
200	O
Hz	O
(	O
E	O
/	O
I	O
LF	O
)	O
was	O
correlated	O
with	O
the	O
presence	O
of	O
airway	O
inflammation	O
and	O
airway	B:C0001883
obstruction	I:C0001883
.	O

We	O
classified	O
asthma	B:C0004096
patients	O
by	O
airway	O
inflammation	O
phenotype	O
using	O
the	O
induced	O
sputum	I:C3179346
eosinophil	O
and	O
neutrophil	O
ratio	O
and	O
determined	O
whether	O
this	O
phenotype	O
could	O
be	O
predicted	O
using	O
E/I	O
LF	O
and	O
fractional	O
exhaled	O
nitric	O
oxide	O
values	O
.	O

We	O
classified	O
asthma	O
patients	O
by	O
airway	B:C0458827
inflammation	O
phenotype	O
using	O
the	O
induced	O
sputum	I:C3179346
eosinophil	O
and	O
neutrophil	O
ratio	O
and	O
determined	O
whether	O
this	O
phenotype	O
could	O
be	O
predicted	O
using	O
E/I	O
LF	O
and	O
fractional	O
exhaled	O
nitric	O
oxide	O
values	O
.	O

We	O
classified	O
asthma	O
patients	O
by	O
airway	O
inflammation	B:C0021368
phenotype	O
using	O
the	O
induced	O
sputum	I:C3179346
eosinophil	O
and	O
neutrophil	O
ratio	O
and	O
determined	O
whether	O
this	O
phenotype	O
could	O
be	O
predicted	O
using	O
E/I	O
LF	O
and	O
fractional	O
exhaled	O
nitric	O
oxide	O
values	O
.	O

We	O
classified	O
asthma	O
patients	O
by	O
airway	O
inflammation	O
phenotype	O
using	O
the	O
induced	B:C3179346
sputum	I:C3179346
eosinophil	O
and	O
neutrophil	O
ratio	O
and	O
determined	O
whether	O
this	O
phenotype	O
could	O
be	O
predicted	O
using	O
E/I	O
LF	O
and	O
fractional	O
exhaled	O
nitric	O
oxide	O
values	O
.	O

We	O
classified	O
asthma	O
patients	O
by	O
airway	O
inflammation	O
phenotype	O
using	O
the	O
induced	O
sputum	I:C3179346
eosinophil	B:C0014467
and	O
neutrophil	O
ratio	O
and	O
determined	O
whether	O
this	O
phenotype	O
could	O
be	O
predicted	O
using	O
E/I	O
LF	O
and	O
fractional	O
exhaled	O
nitric	O
oxide	O
values	O
.	O

We	O
classified	O
asthma	O
patients	O
by	O
airway	O
inflammation	O
phenotype	O
using	O
the	O
induced	O
sputum	I:C3179346
eosinophil	O
and	O
neutrophil	B:C0027950
ratio	O
and	O
determined	O
whether	O
this	O
phenotype	O
could	O
be	O
predicted	O
using	O
E/I	O
LF	O
and	O
fractional	O
exhaled	O
nitric	O
oxide	O
values	O
.	O

Steroid	B:C0004096
-	I:C0004096
naive	I:C0004096
bronchial	I:C0004096
asthma	I:C0004096
patients	O
were	O
classified	O
into	O
four	O
phenotypes	O
,	O
including	O
"	O
Low	O
inflammation	O
"	O
(	O
35	O
patients	O
)	O
,	O
"	O
Eosinophilic	O
type	O
"	O
(	O
58	O
patients	O
)	O
,	O
"	O
Neutrophilic	O
type	O
"	O
(	O
15	O
patients	O
)	O
,	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
15	O
patients	O
)	O
based	O
on	O
the	O
results	O
of	O
induced	O
sputum	I:C3179346
examinations	O
.	O

Steroid	O
-	I:C0004096
naive	I:C0004096
bronchial	I:C0004096
asthma	I:C0004096
patients	O
were	O
classified	B:C0008902
into	O
four	O
phenotypes	O
,	O
including	O
"	O
Low	O
inflammation	O
"	O
(	O
35	O
patients	O
)	O
,	O
"	O
Eosinophilic	O
type	O
"	O
(	O
58	O
patients	O
)	O
,	O
"	O
Neutrophilic	O
type	O
"	O
(	O
15	O
patients	O
)	O
,	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
15	O
patients	O
)	O
based	O
on	O
the	O
results	O
of	O
induced	O
sputum	I:C3179346
examinations	O
.	O

Steroid	O
-	I:C0004096
naive	I:C0004096
bronchial	I:C0004096
asthma	I:C0004096
patients	O
were	O
classified	O
into	O
four	O
phenotypes	O
,	O
including	O
"	O
Low	O
inflammation	B:C0021368
"	O
(	O
35	O
patients	O
)	O
,	O
"	O
Eosinophilic	O
type	O
"	O
(	O
58	O
patients	O
)	O
,	O
"	O
Neutrophilic	O
type	O
"	O
(	O
15	O
patients	O
)	O
,	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
15	O
patients	O
)	O
based	O
on	O
the	O
results	O
of	O
induced	O
sputum	I:C3179346
examinations	O
.	O

Steroid	O
-	I:C0004096
naive	I:C0004096
bronchial	I:C0004096
asthma	I:C0004096
patients	O
were	O
classified	O
into	O
four	O
phenotypes	O
,	O
including	O
"	O
Low	O
inflammation	O
"	O
(	O
35	O
patients	O
)	O
,	O
"	O
Eosinophilic	B:C3687252
type	O
"	O
(	O
58	O
patients	O
)	O
,	O
"	O
Neutrophilic	O
type	O
"	O
(	O
15	O
patients	O
)	O
,	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
15	O
patients	O
)	O
based	O
on	O
the	O
results	O
of	O
induced	O
sputum	I:C3179346
examinations	O
.	O

Steroid	O
-	I:C0004096
naive	I:C0004096
bronchial	I:C0004096
asthma	I:C0004096
patients	O
were	O
classified	O
into	O
four	O
phenotypes	O
,	O
including	O
"	O
Low	O
inflammation	O
"	O
(	O
35	O
patients	O
)	O
,	O
"	O
Eosinophilic	O
type	O
"	O
(	O
58	O
patients	O
)	O
,	O
"	O
Neutrophilic	B:C0021368
type	O
"	O
(	O
15	O
patients	O
)	O
,	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
15	O
patients	O
)	O
based	O
on	O
the	O
results	O
of	O
induced	O
sputum	I:C3179346
examinations	O
.	O

Steroid	O
-	I:C0004096
naive	I:C0004096
bronchial	I:C0004096
asthma	I:C0004096
patients	O
were	O
classified	O
into	O
four	O
phenotypes	O
,	O
including	O
"	O
Low	O
inflammation	O
"	O
(	O
35	O
patients	O
)	O
,	O
"	O
Eosinophilic	O
type	O
"	O
(	O
58	O
patients	O
)	O
,	O
"	O
Neutrophilic	O
type	O
"	O
(	O
15	O
patients	O
)	O
,	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
15	O
patients	O
)	O
based	O
on	O
the	O
results	O
of	O
induced	B:C3179346
sputum	I:C3179346
examinations	O
.	O

Steroid	O
-	I:C0004096
naive	I:C0004096
bronchial	I:C0004096
asthma	I:C0004096
patients	O
were	O
classified	O
into	O
four	O
phenotypes	O
,	O
including	O
"	O
Low	O
inflammation	O
"	O
(	O
35	O
patients	O
)	O
,	O
"	O
Eosinophilic	O
type	O
"	O
(	O
58	O
patients	O
)	O
,	O
"	O
Neutrophilic	O
type	O
"	O
(	O
15	O
patients	O
)	O
,	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
15	O
patients	O
)	O
based	O
on	O
the	O
results	O
of	O
induced	O
sputum	I:C3179346
examinations	B:C0582103
.	O

The	O
E/I	O
LF	O
data	O
and	O
FeNO	O
levels	O
were	O
then	O
evaluated	O
for	O
the	O
four	O
phenotype	O
groups	O
;	O
the	O
prediction	O
powers	O
of	O
these	O
two	O
indices	B:C0918012
were	O
then	O
analyzed	O
for	O
each	O
phenotype	O
.	O

The	O
E/I	O
LF	O
data	O
and	O
FeNO	O
levels	O
were	O
then	O
evaluated	O
for	O
the	O
four	O
phenotype	O
groups	O
;	O
the	O
prediction	O
powers	O
of	O
these	O
two	O
indices	O
were	O
then	O
analyzed	B:C0936012
for	O
each	O
phenotype	O
.	O

The	O
median	O
E/I	O
LF	O
value	O
was	O
highest	O
in	O
the	O
"	O
Mixed	O
type	O
"	O
and	O
lowest	O
in	O
the	O
"	O
Low	O
inflammation	B:C0021368
"	O
group	O
.	O

FeNO	O
differentiated	O
between	O
the	O
"	O
Low	O
inflammation	B:C0021368
"	O
and	O
"	O
Eosinophilic	O
type	O
"	O
groups	O
,	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Neutrophilic	O
type	O
"	O
groups	O
,	O
and	O
"	O
Neutrophilic	O
type	O
"	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
p	O
<	O
0.0001	O
,	O
p	O
=	O
0.007	O
,	O
and	O
p	O
=	O
0.04	O
,	O
respectively	O
)	O
.	O

FeNO	O
differentiated	O
between	O
the	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Eosinophilic	B:C3687252
type	O
"	O
groups	O
,	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Neutrophilic	O
type	O
"	O
groups	O
,	O
and	O
"	O
Neutrophilic	O
type	O
"	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
p	O
<	O
0.0001	O
,	O
p	O
=	O
0.007	O
,	O
and	O
p	O
=	O
0.04	O
,	O
respectively	O
)	O
.	O

FeNO	O
differentiated	O
between	O
the	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Eosinophilic	O
type	O
"	O
groups	O
,	O
"	O
Low	O
inflammation	B:C0021368
"	O
and	O
"	O
Neutrophilic	O
type	O
"	O
groups	O
,	O
and	O
"	O
Neutrophilic	O
type	O
"	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
p	O
<	O
0.0001	O
,	O
p	O
=	O
0.007	O
,	O
and	O
p	O
=	O
0.04	O
,	O
respectively	O
)	O
.	O

FeNO	O
differentiated	O
between	O
the	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Eosinophilic	O
type	O
"	O
groups	O
,	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Neutrophilic	B:C0021368
type	O
"	O
groups	O
,	O
and	O
"	O
Neutrophilic	O
type	O
"	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
p	O
<	O
0.0001	O
,	O
p	O
=	O
0.007	O
,	O
and	O
p	O
=	O
0.04	O
,	O
respectively	O
)	O
.	O

FeNO	O
differentiated	O
between	O
the	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Eosinophilic	O
type	O
"	O
groups	O
,	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Neutrophilic	O
type	O
"	O
groups	O
,	O
and	O
"	O
Neutrophilic	B:C0021368
type	O
"	O
and	O
"	O
Mixed	O
type	O
"	O
(	O
p	O
<	O
0.0001	O
,	O
p	O
=	O
0.007	O
,	O
and	O
p	O
=	O
0.04	O
,	O
respectively	O
)	O
.	O

E/I	O
LF	O
differentiated	O
between	O
the	O
"	O
Low	O
inflammation	B:C0021368
"	O
and	O
"	O
Eosinophilic	O
type	O
"	O
groups	O
(	O
p	O
=	O
0.006	O
)	O
.	O

E/I	O
LF	O
differentiated	O
between	O
the	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Eosinophilic	B:C3687252
type	O
"	O
groups	O
(	O
p	O
=	O
0.006	O
)	O
.	O

E/I	O
LF	O
could	O
distinguish	O
the	O
"	O
Mixed	O
type	O
"	O
group	O
from	O
the	O
"	O
Low	O
inflammation	B:C0021368
"	O
and	O
"	O
Eosinophilic	O
type	O
"	O
groups	O
(	O
p	O
=	O
0.002	O
)	O
.	O

E/I	O
LF	O
could	O
distinguish	O
the	O
"	O
Mixed	O
type	O
"	O
group	O
from	O
the	O
"	O
Low	O
inflammation	O
"	O
and	O
"	O
Eosinophilic	B:C3687252
type	O
"	O
groups	O
(	O
p	O
=	O
0.002	O
)	O
.	O

A	O
combination	O
of	O
the	O
E/I	O
LF	O
value	O
and	O
FeNO	O
may	O
be	O
useful	O
for	O
the	O
classification	B:C0008902
of	O
the	O
airway	O
inflammation	O
phenotype	O
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
.	O

A	O
combination	O
of	O
the	O
E/I	O
LF	O
value	O
and	O
FeNO	O
may	O
be	O
useful	O
for	O
the	O
classification	O
of	O
the	O
airway	B:C0458827
inflammation	O
phenotype	O
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
.	O

A	O
combination	O
of	O
the	O
E/I	O
LF	O
value	O
and	O
FeNO	O
may	O
be	O
useful	O
for	O
the	O
classification	O
of	O
the	O
airway	O
inflammation	B:C0021368
phenotype	O
in	O
patients	O
with	O
bronchial	O
asthma	I:C0004096
.	O

A	O
combination	O
of	O
the	O
E/I	O
LF	O
value	O
and	O
FeNO	O
may	O
be	O
useful	O
for	O
the	O
classification	O
of	O
the	O
airway	O
inflammation	O
phenotype	O
in	O
patients	O
with	O
bronchial	B:C0004096
asthma	I:C0004096
.	O

